Rupak Mukherjee
Overview
Explore the profile of Rupak Mukherjee including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
127
Citations
1784
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Figueroa M, Hall S, Mattia V, Mendoza A, Brown A, Xiong Y, et al.
JVS Vasc Sci
. 2023 Nov;
4:100124.
PMID: 37920479
Objective: The objective of this investigation was to demonstrate that in vivo induction of hypertension (HTN) and in vitro cyclic stretch of aortic vascular smooth muscle cells (VSMCs) can cause...
12.
Batten M, Mukherjee R, Walter T, Lancaster W
J Cancer
. 2023 Oct;
14(16):3099-3107.
PMID: 37859816
Black patients have the highest overall incidence rate of early onset colorectal cancer, with many of these patients presenting with more aggressive disease at diagnosis, ultimately leading to decreased overall...
13.
Gail M, Sims-Robinson C, Boger H, Ergul A, Mukherjee R, Jenkins D, et al.
Brain Stimul
. 2023 Aug;
16(5):1240-1242.
PMID: 37619892
No abstract available.
14.
Barker C, Chung C, Mukherjee R, Siegel J, Cole D, Lockett M, et al.
Breast Cancer Res Treat
. 2023 Aug;
202(1):129-137.
PMID: 37584883
Purpose: High-risk breast pathology is a breast cancer risk factor for which timely treatment is crucial. Nurse navigation programs have been implemented to minimize delays in patient care. This study...
15.
Siegel J, Mukherjee R, DeChamplain B, Sutton J, Mahvi D, Lancaster W
Am Surg
. 2023 Jul;
90(1):28-37.
PMID: 37518065
Background: Although randomized controlled trials on neoadjuvant chemotherapy for gastric cancer have included some T1-staged tumors, overall survival (OS) has not been analyzed for this subset. Due to the low...
16.
Patel R, Hall S, Lanford H, Ward N, Grespin R, Figueroa M, et al.
Vasc Endovascular Surg
. 2023 Jan;
57(5):433-444.
PMID: 36639147
Introduction: Elevated interleukin-6 (IL-6) plasma levels have been associated with abdominal aortic aneurysm (AAA), but whether this cytokine plays a causative role in the degenerative remodeling or represents an effect...
17.
Beck T, Arhontoulis D, Morningstar J, Hyams N, Stoddard A, Springs K, et al.
JACC CardioOncol
. 2022 Nov;
4(4):535-548.
PMID: 36444237
Background: Trametinib is a MEK1 (mitogen-activated extracellular signal-related kinase kinase 1) inhibitor used in the treatment of BRAF (rapid accelerated fibrosarcoma B-type)-mutated metastatic melanoma. Roughly 11% of patients develop cardiomyopathy...
18.
19.
Quinn K, Campbell L, Mukherjee R, Abbott A, Streck C
J Surg Res
. 2022 Aug;
279:592-597.
PMID: 35926309
Introduction: For decades, the three-digit United States Medical Licensing Exam Step 1 score has been used to competitively evaluate and compare candidates during the residency application process. Starting in 2022,...
20.
Adams L, Mukherjee R, Hollinger L
Pediatr Surg Int
. 2022 May;
38(7):985-991.
PMID: 35596085
Introduction: This study tested the hypothesis that complication accrual during pediatric extracorporeal life support (ECLS) increases mortality irrespective of indication for support. Methods: Prospectively collected Extracorporeal Life Support Organization (ELSO)...